[HTML][HTML] Young Women with Early-Stage Breast Cancer Treated with Upfront Surgery: Overview of Oncological Outcomes
L Scardina, B Carnassale, A Di Leone… - Journal of Clinical …, 2024 - mdpi.com
Background: Breast cancer in young women aged< 40 years is rare and often aggressive
with less favorable survival rates. The lack of systematic screening, later stage at diagnosis …
with less favorable survival rates. The lack of systematic screening, later stage at diagnosis …
[HTML][HTML] Combining Molecular and Traditional Prognostic Factors: A Holistic Approach to Breast Cancer Prognostication
L Moraru, MI Mitranovici, R Moraru, S Voidazan… - Diagnostics, 2024 - ncbi.nlm.nih.gov
Breast cancer is a heterogeneous disease with various morphologies and molecular
features, and it is the second leading cause of cancer death in women in developed …
features, and it is the second leading cause of cancer death in women in developed …
[HTML][HTML] Non-Invasive 3D Breast Tumor Localization: A Viable Alternative to Invasive Tumor Marking
D Bjelica, N Colakovic, S Opric, D Zdravkovic… - Cancers, 2024 - mdpi.com
Simple Summary Tumor marking before neoadjuvant systemic therapy (NAST) is an
essential part of early breast cancer treatment, aiming to enable adequate surgical excision …
essential part of early breast cancer treatment, aiming to enable adequate surgical excision …
[HTML][HTML] Impact of Neoadjuvant Chemotherapy (NAC) on Biomarker Expression in Breast Cancer
S Lee, JY Kim, SJ Lee, CS Hwang, HJ Lee, KB Kim… - Medicina, 2024 - mdpi.com
Background and Objectives: This study aimed to explore biomarker change after NAC
(neoadjuvant chemotherapy) and to investigate biomarker expression as a prognostic factor …
(neoadjuvant chemotherapy) and to investigate biomarker expression as a prognostic factor …